期刊文献+

携带人肿瘤抑素Tumstatin基因的重组腺相关病毒载体的构建及其在乳腺癌细胞中的表达研究 被引量:4

Construction of Recombinant AAV Vector Mediated Tumstatin Gene and the Detection of Its Expression in Breast Cancer Cell Line MCF-7
原文传递
导出
摘要 目的构建携带人肿瘤抑素Tumstatin基因的重组腺相关病毒载体,研究其在乳腺癌细胞MCF-7中的表达。方法以人胚肾293细胞为材料,用RT-PCR方法获取人肿瘤抑素Tumstatin基因,将其克隆入pAAV-MCS载体中形成重组载体pAAV-Tum质粒。用脂质体介导法将重组载体导入乳腺癌细胞株(MCF-7)建立一株稳定的表达Tumstatin基因的乳腺癌细胞株MCF/AAV-Tum,并用RT-PCR检测该细胞系中Tumstatin基因的表达。结果成功构建了pAAV-Tum重组腺相关病毒载体,筛选出乳腺癌细胞株MCF/AAV-Tum,该细胞能表达Tumstatin基因。结论构建的pAAV-Tum重组载体能在MCF-7细胞中表达,为其后的肿瘤抗血管生成治疗研究奠定了基础。 Objective To construct the recombinant adeno-associated virus(rAAV) vector containing Tumstatin gene,and to detect its expression in the MCF-7 cells.Methods The cDNA fragment of Tumstatin was obtained by a reverse transcriptasepolymerase chain reaction(RT-PCR) with total RNA extracted from 293 embryonic kidney cells.The RT-PCR product was cloned into pAAV-MCS vector,and then the pAAV-Tum plasmid was obtained.Transfection of pAAV-Tum into MCF-7 cells was performed by using lipofectin.An MCF-7 cell line that could stably express Tumstatin gene was established,and then mRNA level of pAAV-Tum was detected by RT-PCR. Results AAV vector,which contained Tumstatin gene,was constructed successfully.An MCF-7 cell line that could stably express Tumstatin gene was established. Conclusions The recombinant vector of pAAV-Tum can express in MCF-7 cell,which will lay a foundation for its anti-angiogenesis therapy of tumor.
出处 《实用预防医学》 CAS 2010年第12期2362-2364,共3页 Practical Preventive Medicine
基金 湖南省教育厅基金资助项目(项目编号:09C153)
关键词 Tumstatin基因 腺相关病毒 基因治疗 Tumstatin gene Adeno-associated virus Gene therapy
  • 相关文献

参考文献7

  • 1黄煌,黄英,易成.肿瘤抑素:一种内源性的肿瘤血管生成抑制因子[J].华西医学,2007,22(4):941-942. 被引量:6
  • 2Hlatky L, Hahnfeldt P, Folkman J. Clinical application of antiangioge- nie therapy: microvessel density, what it does and doesn't tell us[J ]. J Nad Cancer Inst, 2002,94(12) : 883 - 893.
  • 3贺欣,赵启仁,宋娜玲,颜廷东.肿瘤抑素T_7肽及其衍生物T_7-NGR载体构建及表达[J].生物医学工程与临床,2008,12(3):240-244. 被引量:9
  • 4Harnano Y, Zeisberg M, Sugimoto H, et al. Physiological levels of tumstatin, a fragment of collagen Ⅳ alpha 3 chain , are generated by MMP - 9 proteolysis and suppress angiogenesis via alpha V beta 3 in- tegrin[J]. Cancer Cell, 2003,3(6) :589 - 601.
  • 5Boosani CS, Mannam AP, Cosgrove D, et al. Regulation of COX - 2 mediated signaling by { alpha } 3 type Ⅳ noncollagenous domain in tu- mor angiogenesis[ J ]. Blood,2007,110(4) : 1 t68 - 77.
  • 6Gafni Y, Pelled G, Zilberman Y, et al. Gene therapy platform for bone regeneration using an exngenously regulated, AAV - 2 - based gene ex- pression system[J]. Mol Ther, 2004, 9(4): 587-59.
  • 7Lipshutz GS, Titre D, Brindle M. Comparison of gene expression after intraperitoneal delivery of AAV2 or AAV5 in utero[J ]. Mol Ther, 2003, 8(1): 90-98.

二级参考文献10

  • 1王淑静,刘岩,林雪松,付雪,徐建永,刘兴汉.肿瘤抑素抗肿瘤相关肽的克隆及生物活性[J].中国生物化学与分子生物学报,2005,21(3):322-328. 被引量:6
  • 2Maeshima Y,Colorado PC,Kalluri R.Two RGD-independent alpha v beta 3 integrin binding sites on tumstatin regulate distinct anti-tumor properties[J].J Biol Chem,2000,275(31):23745-23750.
  • 3Maeshima Y,Colorado PC,Torre A,et al.Distinct antitumor properties of a type Ⅳ collagen domain derived from basement membrane[J].J Biol Chem,2000,275(28):21340-21348.
  • 4Petitclerc E,Boutaud A,Prestayko A,et al.New functions for non-collagenons domains of human collagen type Ⅳ.Novel integrin ligands inhibiting angiogenesis and tumor growth in vivo[J].J Biol Chem,2000,275(11):8051-8061.
  • 5Arap W,Pasqualini R,Ruoslahti E.Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model[J].Science,1998,279(5349):377-380.
  • 6Pasqualini R,Koivunen E,Kain R,et al.Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis[J].Cancer Res,2000,60(1):722-727.
  • 7Folkman J.Tumor angiogenesis:therapeutic implications[J].N East J Med,1971,285(21):1182-1186.
  • 8Hlatky L,Hahnfeldt P,Folkman J.Clinical application of antiangiogenic therapy:microvessel density,what it does and doesn't tell us[J].J Natl Cancer Inst,2002,94(12):883-893.
  • 9曹佐武.有效分离1kDa小肽的Tricine-SDS-PAGE方法[J].中国生物工程杂志,2004,24(1):74-76. 被引量:78
  • 10王云峰,丁洁.Ⅳ型胶原分子结构的研究与Alport综合征[J].肾脏病与透析肾移植杂志,2004,13(1):71-74. 被引量:14

共引文献9

同被引文献19

  • 1黄煌,黄英,易成.肿瘤抑素:一种内源性的肿瘤血管生成抑制因子[J].华西医学,2007,22(4):941-942. 被引量:6
  • 2Hlatky L, Hahnlel& P, Folkman J. Clinical application of antiangiogenie therapy: mierovessel density, what it does and doesn't tell us[J].J Nad Cancer Inst,2002,94(12) : 883-893.
  • 3Hamano Y, Zeisberg M, Sugimoto H, et al. Physiological levels of tumstatin, a fragment of collagen IV alpha 3 chain,are generated by MMP 9 proteolysis and suppress angiogenesis via alpha V beta 3 integrin[J]. Cancer Cell,2003,3(6) :589 601.
  • 4Boosani CS, Mannam AP, Cosgrove D, et al. Regulation of COX-2 mediated signaling by alpha 3 type IV noncollagenous domain in tumor angiogenesis[J]. Blood, 2007,110 (4) : 1168-1177.
  • 5Pedchenko V, Zent R, Hudson BG. Alpha(V) and alpha (V) beta5 integrins bind both the proximal RGD site andnon-RGD motifs within noncollagenous(NCI) domain of the alpha3 chain of type N collagen: implication for the mechanism of endothelia cell adhesion[J].J Biol Chem, 2004,279(4) :2772-2780.
  • 6Wright JF, Qu G, Tang C, et al. Recombinant adeno-asso dated virus: formulation challenges and strategies for a gene therapy veetor[J].Curt Opin Drug Discov Devel, 2003,6(2) :174-178.
  • 7Wright JF,Qu G,Tang C,Sommer JM.Recombinant adenoassociated Virus:formulation challenges and strategies for a gene therapy vector. Curt Opin Drug Discov Devel . 2003
  • 8BoosaniC S,Mannam A P,Cosgrove D,et al.Regulation of COX-2 mediated signaling by {alpha} 3 typeⅣnoncollagenous domain in tumor angiogenesis. Blood . 2007
  • 9Pedchenko V,Zent R,Hudson BG.Alpha(V) and alpha(V) beta5 intgrins bind both the proxinmal RGD site and non-RGD motifs within noncollagenous(NCI) domain of the alpha3 chain of typeⅣcollgen:implication for the mechanism ofendothelia cell adhesion. Journal of Biological Chemistry . 2004
  • 10Hlatky L,Hahnfeldt P,Folkman J.Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn’t tell us. Journal of the National Cancer Institute . 2002

引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部